AUGUSTA — Pharmaceutical companies, marijuana and casino groups and the state’s largest utility are among the top spenders on lobbying as Maine’s legislative session wraps up.
Maine lawmakers still have to make decisions on bills to allow recreational marijuana sales, address solar rules, increase transparency of prescription costs and allow tribal gaming. This year’s legislative session is set to end in mid-April.
The top spender on lobbying continues to be a California billionaire’s push for a crime victim’s bill of rights in Maine. His group spent $30,000 this year and $120,000 last year to lobby on such legislation, whose future is unclear.
Companies and groups from Central Maine Power to Pharmaceutical Research and Manufacturers of America to Penn National Gaming have reported spending at least $1 million on lobbying this year, according to an Associated Press review of reports filed this month.
DRUG COST TRANSPARENCY
Maine’s largest insurers and the nation’s largest pharmaceutical companies have been sparring for months on a bill to require more disclosure of prescription drug costs.
The Legislature’s Judiciary Committee voted 7-6 last week on an